Search research articles
Contact Us
Filters
Showing results (461-470 of 512) with videos related to
Page
of 52
Sort By:
Nature. Mental Health
|
October 10, 2025
The network-based underpinnings of persisting symptoms after concussion: a multimodal neuroimaging meta-analysis
Adriano Mollica, Robin F H Cash, Carl Froilan D Leochico, et al.
Alzheimer'S Research & Therapy
|
April 28, 2026
Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial
Damien Gallagher, Yejin Kang, Nathan Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2020
Identification of a RAS-activating <i>TMEM87A-RASGRF1</i> Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer
Alissa J Cooper, Yoshihisa Kobayashi, Dewey Kim, et al.
JAMA Oncology
|
August 4, 2018
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib
Geoffrey R Oxnard, Yuebi Hu, Kathryn F Mileham, et al.
Brain Communications
|
November 28, 2022
Cognitive effects of unilateral thalamotomy for tremor: a meta-analysis
Camryn R Rohringer, Isabella J Sewell, Shikha Gandhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2007
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer
David M Jackman, Beow Y Yeap, Neal I Lindeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
David M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Movement Disorders Clinical Practice
|
April 23, 2025
Cognitive Outcomes Following Second-Sided Focused Ultrasound Thalamotomy for Tremor
Silina Z Boshmaf, Julie Petersen, Rohina Kumar, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 2, 2019
Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
Rachel F Buckley, Sietske Sikkes, Victor L Villemagne, et al.
JAMA Network Open
|
August 10, 2019
Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults
Jennifer R Gatchel, Jennifer S Rabin, Rachel F Buckley, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 512) with videos related to
Sort By:
Page
of 52
Nature. Mental Health
|
October 10, 2025
The network-based underpinnings of persisting symptoms after concussion: a multimodal neuroimaging meta-analysis
Adriano Mollica, Robin F H Cash, Carl Froilan D Leochico, et al.
Alzheimer'S Research & Therapy
|
April 28, 2026
Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial
Damien Gallagher, Yejin Kang, Nathan Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2020
Identification of a RAS-activating <i>TMEM87A-RASGRF1</i> Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer
Alissa J Cooper, Yoshihisa Kobayashi, Dewey Kim, et al.
JAMA Oncology
|
August 4, 2018
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib
Geoffrey R Oxnard, Yuebi Hu, Kathryn F Mileham, et al.
Brain Communications
|
November 28, 2022
Cognitive effects of unilateral thalamotomy for tremor: a meta-analysis
Camryn R Rohringer, Isabella J Sewell, Shikha Gandhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2007
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer
David M Jackman, Beow Y Yeap, Neal I Lindeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
David M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Movement Disorders Clinical Practice
|
April 23, 2025
Cognitive Outcomes Following Second-Sided Focused Ultrasound Thalamotomy for Tremor
Silina Z Boshmaf, Julie Petersen, Rohina Kumar, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 2, 2019
Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
Rachel F Buckley, Sietske Sikkes, Victor L Villemagne, et al.
JAMA Network Open
|
August 10, 2019
Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults
Jennifer R Gatchel, Jennifer S Rabin, Rachel F Buckley, et al.
Page
of 52